The DOPPS practice monitor for US dialysis care: Trends through december 2011

American Journal of Kidney Diseases

Volumn 61, Issue 2, 2013, Pages 342-346

  Fuller, Douglas S ^a   Pisoni, Ronald L ^a   Bieber, Brian A ^a   Gillespie, Brenda W ^a   Robinson, Bruce M ^a  

^a ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN; PARATHYROID HORMONE;

ANEMIA; BONE DISEASE; ERYTHROCYTE TRANSFUSION; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; REVIEW;

EID: 84872312475     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.10.002     Document Type: Article

References (11)

1. Arbor Research Collaborative for Health DOPPS Practice Monitor http://www.dopps.org/DPM/Default.aspx Accessed July 4, 2012
2. B.M. Robinson, D.S. Fuller, D. Zinsser The Dialysis Outcomes and Practice Patterns Study (DOPPS) Practice Monitor: rationale and methods for an initiative to monitor the new US bundled dialysis payment system Am J Kidney Dis 57 6 2011 822 831
3. Renal Network of the Upper Midwest Elab Project: National 2010 and Trends Elab Report http://www.esrdnet11.org/Elab/elab-national-2010-and-trends-report. pdf Accessed July 4, 2012
4. B.M. Robinson, D.S. Fuller, B.A. Bieber The DOPPS Practice Monitor for US dialysis care: trends through April 2011 Am J Kidney Dis 59 2 2012 309 312
5. R.L. Pisoni, D.S. Fuller, B.A. Bieber The DOPPS Practice Monitor for US dialysis care: trends through August 2011 Am J Kidney Dis 60 1 2012 160 165
6. Centers for Medicare & Medicaid Services Medicare program; end-stage renal disease prospective payment system Final rule Fed Regist 75 155 2010 49029 49214
7. US Food and Drug Administration FDA Drug Safety Communication: modified dosing recommendations to improve the safe use of erythropoiesis-stimulating agents (ESAs) in chronic kidney disease http://www.fda.gov/drugs/drugsafety/ ucm259639.htm June 24, 2011 Accessed July 4, 2012
8. Centers for Medicare & Medicaid Services Medicare program; changes to the end-stage renal disease prospective payment system for CY 2012, end-stage renal disease quality incentive program for PY 2013 and PY 2014; ambulance fee schedule; and durable medical equipment; proposed rule Fed Regist 76 131 2011 40498 40550
9. Centers for Medicare & Medicaid Services Medicare program; end-stage renal disease prospective payment system and quality incentive program; ambulance fee schedule; durable medical equipment; and competitive acquisition of certain durable medical equipment, prosthetics, orthotics and supplies; final rule Fed Regist 76 218 2011 70228 70316
10. B.J. Manns, M. Tonelli The new FDA labeling for ESA - implications for patients and providers Clin J Am Soc Nephrol 7 2 2012 348 353
11. A.J. Collins ESRD payment policy changes: the new "bundled" dialysis prospective payment system (PPS) in the United States http://www.usrds.org/2012/pres/USDialysisBundle-impact-NKFCM2012.pdf Accessed July 4, 2012